Veracyte (VCYT) Free Cash Flow Growth (3y) (2015 - 2026)
Veracyte (VCYT) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.05% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 23.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 14.16% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 30.41% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.52% |
| 10 | Veracyte | 3.69 Bn | 3.39 Bn | 108.55 Mn | 46.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.62% |
| Mar 31, 2026 | 124.02% |
| Dec 31, 2025 | 100.32% |
| Sep 30, 2025 | 91.22% |
| Jun 30, 2025 | 397.17% |
| Mar 31, 2025 | 33.60% |
| Dec 31, 2024 | 34.23% |
| Sep 30, 2024 | 82.46% |
| Jun 30, 2024 | 115.36% |
| Mar 31, 2024 | 35.70% |
| Dec 31, 2023 | 40.60% |
| Sep 30, 2023 | 66.59% |
| Jun 30, 2023 | 55.94% |
| Mar 31, 2023 | 11.16% |
| Dec 31, 2022 | 57.85% |
| Sep 30, 2022 | 83.09% |
| Jun 30, 2022 | 28.11% |
| Mar 31, 2022 | -111.49% |
| Dec 31, 2021 | 90.03% |
| Sep 30, 2021 | -42.88% |